Crossmark

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies

Crossref DOI link: https://doi.org/10.1186/s40364-025-00869-w

Published Online: 2025-11-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bancos, Anamaria

Ivancuta, Andrei

Moisoiu, Vlad

Tigu, Adrian-Bogdan

Gulei, Diana

Nistor, Madalina

Moldovan, Cristian-Silviu

Kegyes, David

Cenariu, Diana

Zdrenghea, Mihnea

Bojan, Anca

Iancu, Stefania D.

Leopold, Nicolae

Ghiaur, Gabriel

Bumbea, Horia

Tanase, Alina

Einsele, Hermann

Ciurea, Stefan O.

Tomuleasa, Ciprian
License Information

Text and Data Mining valid from 2025-11-28

Version of Record valid from 2025-11-28
More Information

Article History

Received: 16 July 2025

Accepted: 2 November 2025

First Online: 28 November 2025

Declarations

:

: Not applicable

: All authors have read and agreed to the publication. No patient information is reported and thus no patient consent is applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below